Ads
related to: demyelinating polyneuropathy
Search results
Results from the WOW.Com Content Network
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired autoimmune disease of the peripheral nervous system characterized by progressive weakness and impaired sensory function in the legs and arms. [1]
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a neurological disorder -- a condition that targets your body’s nerves. Symptoms aren’t the same for everyone, but you may be tired...
CIDP chronic inflammatory demyelinating polyneuropathy is an autoimmune condition that affects the myelin sheath around your peripheral nerves. This causes worsening symptoms, like muscle weakness and abnormal sensations, over at least eight weeks.
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a slowly developing autoimmune disorder in which the body's immune system attacks the myelin that insulates and protects the body’s nerves.
With CIDP, the immune system’s inflammatory cells mistakenly recognize nerve tissue as foreign, sending cells to attack it. Demyelinating describes the nerve damage. Think of your nerves as copper wires.
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare neurological disorder that affects the nerve roots and peripheral nerves in the body, resulting in weakness/paralysis and impairment in motor function, especially of the arms and legs.
Chronic inflammatory demyelinating polyneuropathy (CIDP; also known as chronic inflammatory demyelinating polyradiculoneuropathy) is an entity that describes a group of related neuropathies, all having chronicity, demyelination, inflammation, and immune mediation in common.
Chronic inflammatory demyelinating polyradiculoneuropathy is an immune-mediated polyneuropathy marked by nerve roots and peripheral nerve inflammation, characterized by segmental demyelination and remyelination.
CIDP is identified by electrodiagnostic and/or pathologic features of demyelination and responsiveness to immunomodulatory treatments. The classification, etiology, clinical features, and diagnosis of CIDP will be reviewed here.
Chronic inflammatory demyelinating polyneuropathy is an immune-mediated polyneuropathy characterized by symmetric weakness of proximal and distal muscles and by progression continuing > 2 months. (See also Overview of Peripheral Nervous System Disorders.)
Ads
related to: demyelinating polyneuropathy